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PNS axons have a high intrinsic regenerative ability while most CNS axons show little 
regenerative response. We show that activation of Neu3 sialidase, also known as 
Neuraminidase-3, causing conversion of GD1a and GT1b to GM1 ganglioside, is an essential 
step in regeneration occurring in PNS (sensory) but not CNS (retinal) axons in adult rat. In 
PNS axons, axotomy activates Neu3 sialidase, increasing the ratio of GM1/GD1a and 
GM1/GT1b gangliosides immediately after injury in vitro and in vivo. No change in the 
GM1/GD1a ratio after axotomy was observed in retinal axons (in vitro and in vivo), despite 
the presence of Neu3 sialidase. Externally applied sialidase converted GD1a ganglioside to 
GM1 and rescued axon regeneration in CNS axons and PNS axons after Neu3 sialidase 
blockade. Neu3 sialidase activation in DRGs is initiated by an influx of extracellular calcium, 
activating P38MAPK then Neu3 sialidase. Ganglioside conversion by Neu3 sialidase further 






Mammalian central nervous system (CNS) axons fail to regenerate after damage while 
peripheral nervous system (PNS) axons can regenerate vigorously, many reconnecting with 
their targets.  Mature CNS axons have been shown to be intrinsically poor at regenerating 
even in permissive environments (Chew et al., 2012; Cho and Cavalli, 2012; Moore and 
Goldberg, 2011; Sun and He, 2010; Wang and Jin, 2011).  Successful axon regeneration 
begins with growth cone formation involving coordinated proteolytic, cytoskeletal and cell 
surface regulatory events (Afshari et al., 2009; Bradke and Dotti, 1999; Erez et al., 2007; 
Long and Lemmon, 2000; Witte et al., 2008) as well as activation of local protein translation 
as in PNS axons (Verma et al., 2005; Zheng et al., 2001).  Integrins and other signalling 
molecules involved with control of regeneration can associate with lipid microdomains, 
leading to the modulation of many intracellular signalling events (Gao et al., 2011; Grider et 
al., 2009; Guirland et al., 2004; Guirland and Zheng, 2007; Kamiguchi, 2006; Norambuena 
and Schwartz, 2011; Stuermer, 2010).  
 
Gangliosides, complex glycosphingolipids on the plasma membrane containing one or more 
sialic acid residues, are key components of microdomains. The adult mammalian nervous 
system has four dominant types of gangliosides, GM1, GD1a, GD1b and GT1b. While 
embryos can develop normally without complex gangliosides, postnatally they develop 
demyelination, neurodegeneration, and impaired peripheral nerve regeneration (Kittaka et 
al., 2008; Okada et al., 2002; Sheikh et al., 1999). GM1 ganglioside has been shown to 
promote axon growth (Facci et al., 1984; Skaper et al., 1985) and regeneration (Mountney et 
al., 2010; Yang et al., 2006), but resulted in an unsuccessful clinical trial of GM1 in spinal 
cord injury (Geisler et al., 2001). GD1a ganglioside on the other hand has been shown to be 
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a receptor for inhibition of axon growth by myelin-associated glycoprotein (MAG) (Vyas et 
al., 2002; Zhang et al., 2011), and GT1b forms a complex with the Nogo receptor to inhibit 
axon growth (Williams et al., 2008). Neu3 sialidase, an enzyme which hydrolyzes polysialic 
acid containing gangliosides to GM1 ganglioside (Geisler et al., 2001; Vyas et al., 2002), acts 
on outer sialic acid groups and has been shown to effectively increase GM1 levels (Monti 
and Miyagi, 2012; Oehler et al., 2002).  Additionally, Neu3 has been shown to be necessary 
for neuronal differentiation (Da Silva et al., 2005), for maintenance of polarity after axotomy 
(Rodriguez et al., 2001), and for regulating invasive and migratory activity (Tringali et al., 
2012; Miyata et al., 2011; Yamaguchi et al., 2006).  
 
In this paper, we examine Neu3 sialidase action on axonal gangliosides and resultant axon 
regeneration, and assess whether these mechanisms help to explain the different 
regeneration capacities of CNS and PNS axons. We find that after PNS axotomy but not CNS, 
Neu3 sialidase converts GD1a to GM1.  Pharmacological blocking of Neu3 sialidase, 
downregulation of Neu3 with siRNA, or depleting gangliosides, all inhibit PNS regeneration.  
Conversely, exogenously applied sialidase increases GM1 ganglioside and promotes 
regeneration in CNS axons, suggesting that conversion of polysialyated gangliosides is 




Materials & Methods 
Chemicals and reagents 




Dorsal root ganglion cultures 
Adult (3–4 mo old) female Sprague-Dawley rats were killed and DRGs removed. Explants: 
DRGs were trimmed of meningeal coverings and divided into segments and plated onto 
coated chamber slides (Nunc) (10μg/ml PDL and 1μg/ml laminin). Explants were maintained 
at 370C and 7%CO2 in DMEM (Invitrogen) with 0.11g/L Sodium pyruvate with pyrodixine, 
4.5g/L glucose, 20ng/ml NGF, 1:100 Insulin-Transferin-Selenium, 1:100 Penicillin-
Streptomycin-Fungizone. Dissociated DRGs: DRGs were dissociated with 0.2% collagenase 
followed by 0.1% trypsin and triturated with Pasteur pipettes of decreasing tip diameters. 
The suspension was centrifuged through a density gradient (15% BSA). Cells were cultured 
in DMEM supplemented with 10% FBS (Invitrogen), 1% Penicillin-Streptomycin-Fungizone, 
0.1% mitomycin-C and 10ng/mL NGF and plated on PDL (20µg/mL) + laminin (10µg/mL). 
Retina explant cultures 
Unilateral conditioning optic nerve crush was performed on adult female Sprague-Dawley 
rats, 7 d before retinal dissection. Retinas were separated from underlying pigment 
epithelium and sclera in HBSS before mounting flat onto petri dishes and cutting into 400μm 
thick sections using a McIiwain tissue chopper (Vibratome, Gorsham Surrey, UK). Retinal 
sections were plated onto plastic chamber slides coated with 300μg/ml PDL and 10μg/ml 
laminin, with the ganglion cell layer facing the substratum.  Cultures were maintained in 
DMEM and Neurobasal–A (Invitrogen) in 1:1 ratio, supplemented with 50 IU erythropoietin-
A, 760μg/ml BSA, N2 supplement (Gibco), 100μg/ml Sodium pyruvate, 4μg/ml of T3-T4, 
2mM glutamine (Invitrogen), 1.1mg/ml glucose, 100 μg/ml gentamycin (Invitrogen) and 





Axon regeneration assay 
Axons were grown for 48 – 72h (DRGs) or 5 – 7 d (retina explants) and then axotomized with 
a pulled glass electrode leaving the site of axotomy clearly demarcated on the plastic 
chamber slide. Axons were photographed immediately, 15min and 1hr after injury and 
assessed for regeneration. Images were captured on a Nikon Phase Contrast ELWD 0.3 
microscope equipped with a Nikon DXM 1200 digital camera using a 10x (10X/0.25) or 20X 
(20X/0.4) objective lens.  For analysis, only cut axons that had retracted and begun to grow 
back were regarded as regenerating axons. 
Pharmacological treatments: 
Inhibition of ganglioside synthesis: Axons were treated with either fumonisin B1 (3μM) or 
PDMP (20μM) 18h before axotomy. 
Modulation of Neu3 sialidase activity: Axons were treated with either 2, 3, dehydro-2, 
deoxy-N-acetylneuraminic acid (NeuAc2en; 800M) for inhibition of Neu3 sialidase activity 
and/or with exogenous Clostridium sialidase (0.4 international units; Roche, UK), 
immediately before axotomy. NeuAc2en was removed before adding Clostridium sialidase 
as NeuAc2en inhibited Clostridium sialidase activity. 
Modulation of signalling pathways: To analyze the regulation of Neu3 sialidase activity after 
adult DRG axotomy, one of the following was added to the media 30mins before axotomy 
and left in the media for further 60mins: U0126 (MEK-ERK inhibitor, 20μM, Promega, UK), 
rapamycin (mTOR inhibitor, 10nM, Calbiochem), SB203580 (P38MAPK inhibitor, 5μM, 
Calbiochem). Anisomycin (10μM, Alomone labs) was used to activate P38MAPK. 
To examine the effect of absence of eCa2+ on Neu3 sialidase activity and axonal 
regeneration, cultures were incubated with normal growth media devoid of CaCl2, 30mins 




Dissociated DRGs were transfected with siRNA 48h after plating. The Neu3 siRNA consists of 
four siRNA sequences: GCAGAGAUGCGUACCUCAA, CCAACAACUCUGCGAGCCU, 
CCAAACAAAUUCCGAGCAG and GGACAGGGCUUGUUCGCGU (ON-TARGETplus SMART pool 
rat Neu3 siRNA, 117185, Thermo Scientific).  siGLO RISC-Free siRNA (Thermo Scientific) was 
used as a negative control and transfection indicator. Briefly, DharmaFECT 3 (Thermo 
Scientific) and siRNA were diluted separately in serum-free DMEM supplemented with 1% 
Insulin-Transferin-Selenium and 10ng/mL NGF before mixing together and incubating with 
the DRGs (100nM; 4h) before replacing with normal medium. 
RNA purification and RT-PCR 
Dissociated DRGs were lysed and collected as per manufacturer’s instructions (PureLink RNA 
Mini Kit, Invitrogen) before being homogenized (Ultra-Turrax T8 homogenizer, IKA-Werke). 
RNA purification was performed before reverse-transcription.  The purified RNA was then 
reverse-transcribed using the SuperScript III First-Strand Synthesis SuperMix (Invitrogen). 
The cDNA synthesis reaction was followed by PCR with the following primers (Neu3, 
forward: 5’-CAGCTGGGATAGCAGAGGTC-3’, reverse: 5’-GAGTCCTGAAGCAAGCCAAC-3’, 
resulting in a 209bp fragment; NEU4, forward: 5’-CCTGACCCTAGGACGAACAG-3’, reverse: 5’-
GATGTGCGTGGTGATCAGAG-3’, resulting in a 179bp fragment). The PCR was run at 26, 29 
and 32 cycles, separately, and imaged using agarose gel electrophoresis.    
Immunocytochemical staining of cultures: 
Both DRG and retina explant cultures were fixed with 4% PFA for 10 min and washed with 
PBS before immunostaining. To analyze Neu3 sialidase activity, we calculated the relative 
levels of GD1a (substrate) and GM1 (product) on individual axonal membrane rather than 
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absolute mean values of GD1a and GM1 ganglioside. Mean of 30-60 axons per chamber (2 
DRGs/chamber) was considered as n=1/experimental condition. Fixed cultures were 
incubated with one of the following antibodies: rabbit anti Neu3 sialidase/PMGS (Rodriguez 
et al., 2001), mouse anti-GD1a ganglioside (Kind gift of Prof Ronald Schnaar, Johns Hopkins 
Univ), mouse anti-GD1a ganglioside and mouse anti-GT1b ganglioside (Merck Millipore, UK) 
or stained using recombinant CTB conjugated to Alexa fluor 555 (Invitrogen, UK), and mouse 
anti β3-tubulin. To analyze the signalling cascade regulating Neu3 sialidase activity, DRG and 
retinal cultures were analysed with the following primary antibodies: mouse anti-P38MAPK, 
rabbit anti-phospho P38MAPK, rabbit anti-ERK and mouse anti-phospho ERK (Cell Signalling 
Technology, USA). Subsequently, cultures were washed in PBS and incubated with the 
following fluorescent secondary antibodies: anti-rabbit Alexa fluor 660, and anti-mouse or 
anti-rabbit Alexa fluor 488 (Invitrogen, UK) before being mounted onto slides using 
Fluorosave (Calbiochem).  
Surgeries 
All surgeries were performed in accordance with the United Kingdom Animals (Scientific 
Procedures) Act of 1986 and UK Home Office regulations. Adult (2-3 mo old) female 
Sprague-Dawley rats were used for all in vivo experiments. Animals were kept in 12h 
light/dark exposure and food and water was provided ad libitum.  
Animals were anesthetized using 1 – 2% isofluorane in a mixture of 50% nitrous oxide and 
50% oxygen for sciatic nerve surgery.  The right sciatic nerve was exposed and crushed 
proximal to its division into tibial and common peroneal nerves with Dumont #5 forceps, 
crushing twice for 10s duration each.  
Optic nerve crushes were performed under ketamine:xylazine (2:1) anesthesia at a dosage 
of 0.1ml/100g. The conjunctiva of the right optic nerve was cut laterally near the cornea and 
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the retractor bulbar muscle was separated. The optic nerve was exposed and cleared of 
fascial coverings and crushed twice for 10s duration each time.  
Immunohistochemistry 
Animals were sacrificed with an overdose of Euthatal (sodium pentobarbitol) at different 
time points after injury (2, 6, and 12h) and transcardially perfused with PBS (pH 7.4) and 4% 
PFA (pH 7.4). A 2cm long segment of sciatic or optic nerve centered around the crush site 
(or contralateral control nerves) was removed and postfixed overnight in 4% PFA before 
cryoprotecting in 30% sucrose in PBS (pH 7.4). Tissue was embedded in OCT (RA Lamb, UK) 
and sectioned longitudinally at 12μm (sciatic nerve) or at 10μm (optic nerve) thickness in a 
cryostat and mounted on slides (Superfrost Plus; VWR). 
Sections were permeabilized in 0.2% saponin in PBS and blocked with 10% NGS and 2% BSA 
in PBS before incubating with one of the following antibodies: rabbit anti neurofilament – 
heavy chain (sciatic nerve) or rabbit anti-βIII tubulin, mouse anti-GD1a, CTB (for GM1 
ganglioside) and anti-S100β. Sections were rinsed in PBS-Saponin before incubating with 
appropriate secondary antibodies, and coverslipping with Fluorosave. 
Quantification of Immunofluorescence 
In vitro: Photographs of cut axons were captured on a Leica DM6000B epifluorescent 
microscope equipped with a Leica DFC 350FX digital camera (Leica, Germany) using a 40x 
objective lens (40X/1.00-0.50 Oil). Image acquisition using Leica Application Suite utilized 
identical exposure times and microscope settings. Quantification of images was performed 
using NIH Image – J software.  
In vivo: Photographs of sciatic (SN) and optic nerve (ON) sections adjacent to the crush site 
were captured using a Leica TCS SP2 confocal microscope (Leica, Germany) using 40x 
(40X/1.15 Oil CS) (for SN) or 63x (63X/1.30 Oil CS) (for ON) magnification. Image acquisition 
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using Leica Application Suite utilized identical exposure times and microscope settings. 
Image quantification was performed using confocal software utilizing optical sections 
(0.800μm thick) to analyze the levels of GM1 and GD1a gangliosides parallel and between 
axonal and Schwann cell markers. Areas of interest were randomly chosen based on areas 
adjacent and parallel to NF-H positive staining from a single confocal image. Intensities were 
measured as ratio of CTB (for GM1 ganglioside):GD1a ganglioside normalized against 
background. In experiments where CTB or Neu3 sialidase intensity was measured, 
normalization was performed using intensity of an axonal marker, βIII-Tubulin. To ensure 
that intensity differences were not due to differences in axon size, intensity measurements 
were normalized for the area of individual axon.  Images were processed with Adobe 
Photoshop CS4 and assembled in Adobe Illustrator CS4. 
Statistical analysis 
Data was first analyzed for normality using Shapiro-Wilk normality test (Origin Ver. 8; 
Originlab Corporation). P values of all data were above set alpha levels of 0.05 and therefore 
considered to be normally distributed.  Results from the analyses were expressed as mean ± 
SEM. Statistical analysis was performed using Prism ver. 5 (Graphpad, USA). For all 
experiments, Student’s t-test (two-tailed), one-way ANOVA and two-way ANOVA were 
applied as appropriate. Significant interactions were analyzed using paired t-tests and 









Axotomy leads to an increase in the ratio of GM1/GD1a gangliosides due to Neu3 sialidase 
activation  
As a model of the first steps in successful axon regeneration, we used regeneration of 
growth cones in adult dorsal root ganglion (DRG) axons grown on poly-D-lysine 
(PDL)/laminin.  These axons regenerate a new growth cone and begin to elongate within 30 
mins after axotomy (Chierzi et al., 2005). We investigated levels of GM1 and GD1a 
gangliosides on these axons and asked whether their relative levels change after axotomy 
and during successful neurite regeneration. Both DRG explant and dissociated cultures were 
fixed at 15mins or 1h after axotomy and stained with Cholera toxin-b subunit (CTB -  marker 
for GM1 ganglioside which we use throughout the paper to label GM1) and anti-GD1a 
ganglioside antibody (Fig. 1). Axotomy led to conversion of most of the GD1a to GM1, the 
ratio of GM1/GD1a having doubled within 15mins and returned back to uncut levels by 1 h 
(Fig. 1A-C, G, H-J, N). The change in the ratio was observed along the entire length of axons 
in our field of observation (200-300μm from the proximal end of cut axons).  Results are 
expressed as a ratio between GM1 and GD1a since absolute levels in individual axons vary 
depending on axon size while the ratio varies little, serving as a more representative 
indicator of local Neu3 sialidase activity on axons. The overall ganglioside level, measured as 
GD1a + GM1 did not change significantly after axotomy, or after other our interventions 
except for inhibition of ganglioside synthesis (data not shown).  Since desialylation of GD1a 
to produce GM1 on the cell surface is usually mediated by Neu3 sialidase, we confirmed the 
presence of Neu3 sialidase on DRG axons by immunostaining using an antibody described 
previously (Rodriguez et al., 2001) (Fig. 1V). Axons were immunolabeled without 
permeabilization demonstrating the presence of Neu3 sialidase on the axonal surface, which 
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could be removed by inhibition of cholesterol synthesis with lovastatin or using methyl β 
cyclodextrin (data not shown) additionally confirming its presence in cholesterol-rich 
domains (Kalka et al., 2001; Kopitz et al., 1996; Miyagi et al., 2008). To verify that conversion 
of GD1a to GM1 is due to the action Neu3 sialidase, we blocked its activity in DRG explant 
cultures using the specific sialidase inhibitor, NeuAc2en (Rodriguez et al., 2001), or in 
dissociated DRG cultures with siRNA for NEU3, the gene which generates Neu3 sialidase. 
The increase in GM1 after axotomy was greatly reduced by NeuAc2en treatment; there was 
only a small change in the GM1/GD1a ratio after axotomy (Fig. 1D-F, G).  Using RNA 
interference for NEU3, we further confirmed that a reduction in Neu3 sialidase prevented 
the change in the GM1/GD1a ratio post-axotomy (Fig. 1K-M, N; controls described below).  
Furthermore, as Neu3 sialidase acts to convert many gangliosides including GD1a, GT1b, 
GD1b, and GQ1b to GM1, we investigated whether GT1b was also affected by axotomy.   
Comparable to GD1a, axotomy led to conversion of GT1b to GM1, the ratio of GM1/GT1b 
having almost tripled within 15mins and decreasing back near uncut levels by 1h (Fig. 1O-Q, 
U).  After siRNA knockdown of Neu3, the GM1/GT1b ratio was unchanged after axotomy 
(Fig. 1R-T, U).  To determine whether axotomy increases GM1 conversion through Neu3 
sialidase up-regulation or by activation, we compared Neu3 sialidase protein levels on uncut 
axons and on axons 15 mins after injury by immunocytochemistry (Da Silva et al., 2005; 
Rodriguez et al., 2001). No significant change in Neu3 sialidase staining intensity was 
observed at 15 min following injury (data not shown), suggesting that an increase in Neu3 
sialidase activity rather than an increase in expression or targeting to membrane was 
responsible for the acute rise in GM1/GD1a ratio after axotomy.  These results indicate that 
reduction in Neu3 sialidase activity will reduce the level of desialytion of many gangliosides 
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to GM1.  However, to streamline our analyses for remaining experiments, we have chosen 
to assess changes in the ratio of GM1/GD1a intensity. 
 
Knocking down the expression of Neu3 sialidase with siRNA does not affect the levels of 
closely related sialidases  
In order to verify that the observed effect of knockdown of Neu3 on GM1 and GD1a and 
GT1b was specifically due to Neu3 sialidase, we evaluated expression levels of other related 
sialidases.   After treatment with NEU3 siRNA, RT-PCR demonstrated a distinct reduction in 
Neu3 levels in dissociated DRG cultures while levels of Neu4 remained unaffected (Fig. 1X).  
Immunohistochemical staining for Neu3 sialidase in NEU3 siRNA transfected cultures 
revealed decreases in Neu3 sialidase levels indicating a reduction in Neu3 sialidase protein 
level compared to control cultures (Fig. 1V, W).  As the NEU3 siRNA specifically reduced only 
Neu3, leaving Neu4 constant, our results suggest that changes in Neu3 sialidase activity are 
responsible for the conversion of GD1a (and GT1b) to GM1. 
 
Preventing GM1 up-regulation thus sustaining levels of complex gangliosides inhibits axon 
regeneration after axotomy 
Since Neu3 sialidase activation generates GM1 ganglioside and because it has been shown 
to promote axonogenesis and axon growth, we hypothesized that inhibiting Neu3 sialidase’s 
activity might inhibit regeneration in adult DRG axons. DRG explants (or dissociated DRG 
cultures) were grown for 48h on PDL-laminin, exposed to NeuAc2en for 1h (or siRNA 
transfection for 4h followed by a 1d incubation), axotomized, and regeneration was 
assessed at 15 mins and 1 h.  Compared to untreated cultures (Fig. 2A-B, F-H), NeuAc2en-
treated DRG explants (Fig. 2C-D) and Neu3 siRNA-transfected dissociated DRGs (Fig. 2I-K) 
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showed a marked reduction in regeneration (Fig. 2E, L).  Axons were scored as regenerating 
if a growth cone was present at their tip and they had grown beyond their retraction point 
(Fig. 2B, G). Within dissociated cultures, retraction of axons in controls was most obvious 
within 15min post-axotomy, with regeneration occurring between 15min and 1h. Uncut 
axons within the same cultures continued to grow in the presence of NeuAc2en with normal 
growth cone morphology (Fig. 2C-D).  Additionally we attenuated total ganglioside synthesis 
using two different inhibitors, fumonisinB1 and (±)-threo-1-Phenyl-2-decanoylamino-3-
morpholino-1-propanol hydrochloride (PDMP) and found that adult DRG axon regeneration 
was severely impaired (data not shown). To rule out toxicity from the ganglioside inhibitors, 
we measured the growth rate of uncut axons in the presence of PDMP or NeuAc2en and 
found no difference between treated and control cultures over the same periods (Fig. 2M, 
N) with axon growth in uncut DRG cultures not affected by NeuAc2en (Fig. 2N). These 
results suggest that the GD1a to GM1 conversion mediated by rapid activation of Neu3 
sialidase during the retraction period plays a significant role in the regeneration of cut DRG 
axons. However, high levels of GM1, or likewise reduced levels of complex gangliosides such 
as GD1a, are not needed for the continuing growth of mature axons.   
 
Sciatic nerve crush leads to GD1a to GM1 conversion in vivo 
We next investigated whether the conversion of GD1a to GM1 after axotomy occurs in the 
PNS in vivo. Sciatic nerve crushes were performed in adult rats and the GM1/GD1a 
ganglioside ratio was measured immunohistochemically. In order to visualise changes in the 
vicinity of axon surfaces, we measured the intensity of GD1a and GM1 in single optical 
sections, selecting narrow areas of interest parallel to axons in between S100β-stained 
Schwann cells and βIII-tubulin or neurofilament stained axonal profiles (Fig. 3A’). Normal 
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adult sciatic nerve had a very low ratio of GM1/GD1a (Fig. 3B, B’). However, this ratio 
changed after nerve crush resulting in a 4-fold increase within 6h after crush injury, 
returning back to uncrushed levels by 12h (Fig. 3B-D, E). Because axons and Schwann cells 
are in direct contact we cannot rule out that some of the changes in sciatic nerve occurred 
on Schwann cells, but our in vivo results closely parallel changes we observed on axons in 
vitro albeit with a longer time course. 
 
Exogenous sialidase rescues NeuAc2en-mediated inhibition of Neu3 sialidase activity and 
promotes neurite regeneration 
To confirm the requirement for sialidase action in axon regeneration and to control for non-
specific effects of NeuAc2en, a rescue experiment was performed in cultured DRGs. After 
inhibiting endogenous Neu3 sialidase activity we treated the cultures with exogenous 
sialidase to convert axonal gangliosides to GM1 (NeuAc2en + sialidase).  First, a control 
experiment demonstrated that the effects of NeuAc2en inhibition on axon regeneration 
persist for at least 1h after removal.  Axotomy 30 mins after removing NeuAc2en (NeuAc2en 
+ control) showed that the inhibitory effect of NeuAc2en on Neu3 sialidase activity persisted 
after its removal, as indicated by a lack of increase in the GM1/GD1a ratio (Fig. 4A-C, G). The 
regenerative ability of axons 30mins after NeuAc2en removal remained low, similar to 
cultures in which the inhibitor was still present (Fig. 4H-I,L). 
Having confirmed the persistent blocking of Neu3 sialidase activity after NeuAc2en removal, 
we assessed whether exogenous Clostridium sialidase dissolved in the culture medium could 
convert GD1a to GM1. Application of sialidase increased the GM1/GD1a ratio in uncut axons 
to the level found after axotomy, and axotomy after sialidase treatment did not further 
increase GM1 levels (Fig. 4D-F,G). Treatment of Neu3 sialidase-inhibited cultures with 
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sialidase restored their regenerative ability near to the levels observed in normal conditions 
(Fig. 4H-K, L). These results suggest that GD1a to GM1 ganglioside conversion mediated 
either by Neu3 sialidase or by externally applied sialidase is important for regeneration of 
peripheral axons. 
 
The Neu3 sialidase-mediated transient increase in the ratio of GM1/GD1a ganglioside is 
not observed in retinal axons. 
In light of previous results, we asked if the failure of regeneration of CNS axons might 
involve an inability to increase GM1 after axotomy. For these experiments, an axotomy was 
performed on axons extending from adult rat retinal explants. We have previously shown 
that only 5% of adult retinal axons regenerate after in vitro axotomy compared with 70% of 
adult DRG axons (Chierzi et al., 2005; Verma et al., 2005). The axons usually retract from the 
cut site and form an active retraction bulb, but fail to make a new growth cone.  We found 
that adult retinal axons have a lower ratio of GM1/GD1a gangliosides on their surface than 
DRG axons.  Additionally, there was no conversion of GD1a to GM1 ganglioside 15mins after 
axotomy in retinal axons (Fig. 5A-B). To determine if this was due to low levels of Neu3 
sialidase in retinal axons, its abundance and distribution were assessed by 
immunofluorescence. Similar levels of staining and distribution of Neu3 sialidase to that 
found in DRG cultures was observed (Fig. 5E). To investigate whether the conversion of 
GD1a to GM1 can occur in these axons in the presence of active sialidase, we applied 
exogenous sialidase to retinal cultures. The treatment induced high levels of GM1 
ganglioside on retinal axons, bringing the GM1/GD1a ratio close to that of axotomized or 
sialidase-treated adult DRG axons (Fig. 5C-D, F). These experiments suggest that Neu3 
sialidase is present on adult retinal axons but is not activated by axotomy. 
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To determine if conversion of gangliosides by sialidase activity occurs after damage to the 
CNS in vivo, we performed an optic nerve crush injury in adult rats and measured 
GM1/GD1a levels in narrow regions adjacent to the axonal marker ßIII-tubulin. No change in 
the GM1/GD1a ratio was observed in these axonal regions of the optic nerve after injury 
and the ratio in undamaged nerves was similar to uncrushed sciatic nerve (Fig. 5G-I, G’-I’, J).  
 
Treatment of retinal axons with sialidase increases their regeneration after axotomy 
We next examined whether exogenous sialidase treatment enhances the ability of adult 
retinal axons to regenerate. After axotomy retinal axons showed greater retraction than 
DRG axons, with many axons retracting out of the field of view (Fig. 5K-N, O). Furthermore, 
only 4.8% of control axons regrew 1h post-axotomy beyond their point of initial retraction, 
whereas 21.3% of axons exposed to sialidase regenerated past their retraction point (Fig. 
5P). These results demonstrate that conversion of more complex gangliosides to GM1 
mediated by sialidase is an important component of the regenerative response and that 
exogenous sialidase treatment can enhance regeneration in adult retinal axons in vitro, 
although not to the level seen in sensory axons. 
 
Neu3 sialidase activity is regulated by eCa2+, ERK, and P38MAPK in adult DRG axons after 
axotomy. 
The preceding experiments indicate that axotomy activates Neu3 sialidase in adult DRG 
axons, but not in adult retinal axons, and that Neu3 sialidase activation is necessary for a 
successful regenerative response. We therefore investigated the signalling events that link 
axotomy to Neu3 sialidase activation and then to axon regeneration. Previous work has 
identified three signalling pathways (ERK, P38MAPK and mammalian target of rapamycin or 
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mTOR) (Abe et al., 2010; Agthong et al., 2009; Agthong et al., 2012) as well as a local Ca2+ 
influx (Mandolesi et al., 2004; Cho and Cavalli, 2012; Cho et al., 2013) which are 
activated/occur in response to axotomy and whose inhibition diminishes successful DRG 
axon regeneration (Chierzi et al., 2005; Verma et al., 2005). We confirmed that transient 
inhibition of any of these pathways with standard inhibitors attenuated the ability of adult 
DRG axons to regenerate (Fig. 6).  
Next we asked whether blocking these signalling pathways affected the conversion of GD1a 
to GM1 after axotomy. Removal of eCa2+, inhibition of ERK or P38MAPK prevented the 
axotomy-mediated increase in the GM1/GD1a ratio after axotomy whereas blocking mTOR 
had no effect on the ratio (data shown in Fig. 7 legend). These results suggest that Neu3 
sialidase activation in axotomized adult DRGs is regulated by a signalling cascade involving 
eCa2+, ERK, and P38MAPK. 
Based on our results combined with knowledge of damage responses in other cell types 
where P38MAPK has been shown to be a stress response kinase (Coulthard et al., 2009), we 
hypothesized that after axonal injury, the rapid influx of Ca2+ activates P38MAPK, which in 
turn leads to increased Neu3 sialidase activity. Based on previous work, Neu3 sialidase-
mediated ganglioside conversion leads to increased signalling via the ERK pathway (Da Silva 
et al., 2005). ERK activation acts on axonal growth mechanisms likely as part of a positive 
feedback loop leading to further activation of Neu3 sialidase (See discussion and Fig. 10).  
We first investigated phosphorylation of P38MAPK (pP38MAPK) 15mins after axotomy of 
adult DRG axons in the presence or absence of eCa2+. In the absence of eCa2+, the increase 
in the pP38MAPK/P38MAPK ratio after axotomy was significantly reduced, suggesting that 
P38MAPK is downstream of eCa2+ entry (Fig. 8A-E).  We next assessed whether P38MAPK 
activation could activate Neu3 sialidase. P38MAPK in uncut axons in the absence of eCa2+ 
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was first activated by a common P38MAPK activator, anisomycin (Katoh-Semba et al., 2009; 
Mei et al., 2012), before the surface levels of GM1 and GD1a were measured.  Anisomycin 
treatment led to a mild increase in pP38MAPK/P38MAPK, and this in turn resulted in a 3.5 
fold increase in the ratio of GM1/GD1a.  Although anisomycin is not entirely specific to p38, 
coupled with the other results, the experiment suggests that Neu3 sialidase was activated 
by P38MAPK activation (Fig. 8F-I). Next, we examined whether ganglioside conversion can 
activate the ERK pathway, as demonstrated previously in embryonic neurons (Da Silva et al., 
2005). To test this, we treated uncut adult DRG axons with exogenous sialidase to convert 
GD1a to GM1.  This conversion resulted in an increased ratio of pERK/ERK (Fig. 8J-L). 
Together these results support the proposed signalling events shown in Figure 10. 
 
P38MAPK is not activated in adult retinal axons post-axotomy. 
CNS axotomy has been shown to invoke a large calcium influx (Mandolesi et al., 2004), 
therefore we hypothesized that the block in Neu3 sialidase activation in retinal axons might 
occur at the P38MAPK activation step. We evaluated whether the ratio of 
pP38MAPK/P38MAPK changes 15mins after axotomy in retinal axons as observed in DRG 
axons.  After axotomy, we did not observe an increase in the ratio of either 
pP38MAPK/P38MAPK or pERK/ERK levels (Fig. 9A-F). Therefore, we assessed whether Neu3 
sialidase activation consequent on P38MAPK activation, is operative in retinal axons. 
P38MAPK was activated using anisomycin, and we measured the GM1/GD1a ganglioside 
ratio. Anisomycin treatment led to a 100% increase in the levels of GM1/GD1a ganglioside 




Overall, our experiments indicate that in DRG axons Neu3 sialidase activation after axonal 
injury is triggered by influx of eCa2+ after membrane rupture leading to activation of 
P38MAPK.  However in retinal axons neither P38MAPK nor Neu3 sialidase is activated 
following axotomy.  Active Neu3 sialidase or an externally applied sialidase changes the ratio 
of GM1/GD1a ganglioside, leading to ERK pathway activation and a successful regeneration 
response.   
 
DISCUSSION 
Our study demonstrates that ganglioside composition on axons is important for growth 
cone production, and that conversion of axonal gangliosides to GM1 by the axonal surface 
enzyme Neu3 sialidase is required for adult axon regeneration.  CNS axons lack intrinsic 
regenerative ability, and our results strongly suggest that the lack of Neu3 sialidase 
activation post-axotomy is a factor in this poor regenerative ability. The importance of 
sialidase activity for CNS regeneration is supported by a previous study in which treatment 
of the injured spinal cord with sialidase promoted axon regeneration (Yang et al., 2006) and 
functional recovery (Mountney et al., 2010; Mountney et al., 2013).  Further work has 
shown that conversion of gangliosides to GM1 by Neu3 sialidase is critical during early 
neuronal differentiation for specification of axons (Abad-Rodriguez and Robotti, 2007; Da 
Silva et al., 2005).  Furthermore, poor regeneration of PNS axons has been observed in 
animals that lack complex gangliosides (Kittaka et al., 2008), and following treatment with 
antibodies to GM1 ganglioside (Lehmann et al., 2007; Lopez et al., 2010).   
 
Regulation of Neu3 sialidase activity 
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The action of sialidases such as Neu3 is to remove terminal sialic acid groups, converting 
gangliosides such as GD1a and GT1b to GM1.  Following axotomy of DRG neurons we 
observed a rapid increase in GM1 and a decrease in both GD1a and GT1b, which was 
prevented by Neu3 sialidase inhibition, through pharmacological inhibition or siRNA 
knockdown.  Preventing conversion of axonal gangliosides to GM1 led to failed regeneration 
in PNS axons.  However, replacing Neu3 sialidase with external sialidase after blocking it 
rescued regeneration by inducing an increase in GM1 (and reduction in GD1a).  This 
suggests that PNS axotomy rapidly activates Neu3 sialidase, converting the major nervous 
system gangliosides to GM1.  Within 1h after axotomy, as axons regenerated their growth 
cones, GD1a and GM1 levels reverted to pre-axotomy values implying that Neu3 sialidase 
activation is transient. Although regulatory mechanisms for Neu3 sialidase are unknown, the 
structure of Neu3 sialidase protein has been characterized, revealing potential 
phosphorylation sites on the C-terminus (Miyagi et al., 1999). After in vitro axotomy, there is 
a transient influx of calcium and rapid activation of several signalling pathways, including 
P38MAPK, ERK and PI3 kinase (Chierzi et al., 2005; Liu and Snider 2001; Verma et al., 2005). 
Our results show that blockade of these pathways prevents Neu3 sialidase activation post-
axotomy. The first step in Neu3 sialidase activation is calcium influx into the damaged axon, 
which we found to be necessary for GD1a to GM1 ganglioside conversion, and for activation 
of other signalling pathways. Calcium influx after axotomy initiates several other processes 
involved in regeneration, including activation of calpain and Ca2+-dependent kinases (Chierzi 
et al., 2005; Kamber et al., 2009; Ziv and Spira, 1997).  The next step we identified was 
activation of P38MAPK, a stress-related kinase, activated by stressors including calcium 
(Nozaki et al., 2001). Activation of P38MAPK by anisomycin triggered sialidase activity, 
confirming P38MAPK as a link between axotomy and Neu3 sialidase activation. However, we 
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do not yet know if P38MAPK binds directly to Neu3 sialidase or if it acts via an intermediary 
step. P38MAPK activation has been shown to be essential for efficient axon regeneration 
(Kato et al., 2013; Myers et al., 2003; Nix et al., 2011; Verma et al., 2005).  Axotomy also 
activated ERK, which is a step in the major signalling pathway controlling axon growth 
(Chierzi et al., 2005; Waetzig and Herdegen, 2005).  Neu3 sialidase activation and 
ganglioside conversion is sufficient to activate ERK, confirmed when ERK was activated in 
axons treated with exogenous sialidase. These results suggest that P38MAPK and ERK are 
acting in-parallel within DRG neurons both downstream of the initial calcium influx that 
arises immediately post-axotomy.   This is likely due to the construction of cell surface 
signalling domains (rafts), of which GM1 is a major organizer.  These domains contain 
various activators of signalling pathways such as integrins, growth factor receptors and 
other signalling molecules.  In embryonic neurons, Neu3 sialidase action can affect axons by 
increasing TrkA signalling resulting in ERK activation (Da Silva et al., 2005).    
 
Neu3 sialidase activation fails in CNS axons 
While Neu3 sialidase was activated by axotomy in DRG axons, we observed no such change 
in adult retinal axons, despite the presence of Neu3 sialidase. These results suggest there is 
a failure in the mechanisms required to activate Neu3 after axotomy. Where might 
activation fail?  Axotomy of CNS axons causes calcium influx as in PNS axons (Mandolesi et 
al., 2004) but we did not observe activation of P38MAPK after axotomy in retinal axons. 
Alternatively, if P38MAPK is pharmacologically activated, retinal axons show sialidase 
activity with ganglioside conversion suggesting a defect in the pathway that leads to 
P38MAPK activation in retinal axons.  Interestingly, axonal regeneration in a P38MAPK 
knockout mouse was shown to be substantially lower than in wild-type mice (Kato et al., 
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2013).  It is not clear why there is a differential regulation of P38MAPK between the two 
neuronal types, however, we hypothesize that the differential activity profile of RhoA in CNS 
and PNS axons may partially explain this difference.  It has been shown to be activated by 
the myelin inhibitor Nogo-A (absent in PNS) which acts to suppress P38MAPK levels in CNS 
neurons after (MCAO) injury (Kilic et al., 2010), inhibiting regeneration.  There is also 
evidence demonstrating that the formation of a complex between GT1b and the Nogo 
receptor NgR1 leads to a lack of axon growth in cerebellar granular neurons (Williams, et al., 
2008).  Likewise, upregulation of cytokines following injury, such as tumor necrosis factor-
alpha (TNF-), has also been shown to activate RhoA in cultured hippocampal neurons 
leading to reduced P38MAPK activation  (Neumann et al., 2002).  However, TNF- has an 
opposite effect in DRG neurons leading to increases in post-injury calcium influx and 
activation of P38MAPK (Pollock et al., 2002).  
 
Actions of Neu3 sialidase 
Neu3 sialidase is membrane-associated and its action is known to be specific to membrane 
gangliosides (Miyagi et al., 1999).  Neu3 sialidase might affect axon regeneration in several 
ways.  In one well-established mechanism, GD1a is a co-receptor for the inhibitory molecule 
MAG, present on PNS and CNS myelinating cells (Collins et al., 1997; Vyas et al., 2002). 
Conversion of GD1a to GM1 therefore diminishes inhibition by MAG. While important in 
vivo, where axons and myelinating glia are in close contact, it is not likely the mechanism 
behind the positive effect of sialidase in our in vitro assays as these axons were not in 
contact with Schwann cells or oligodendrocytes, and inhibition of ganglioside synthesis 
blocked rather than stimulated axon regeneration.  Instead, our results suggest a positive 
effect of GM1 on axon regeneration although we equally realize that this effect could be 
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due to a reduction of complex gangliosides such as GD1a or GT1b.  All interventions that 
increased axonal GM1 increased regeneration and those that inhibited conversion of 
polysialylated gangliosides to GM1 blocked regeneration.  This conclusion is strengthened 
by our results with axotomized retinal axons, which do not up-regulate GM1 ganglioside and 
fail to regenerate unless treated with sialidase to convert surface gangliosides to GM1.  
Potential mechanisms have been proposed to explain how GM1 might enable growth cone 
regeneration, mostly based on the ability of GM1 to organize lipid-rich microdomains/rafts.  
Disruption of one type of raft through manipulation of flotillins affects regeneration, for 
example (Stuermer, 2010).  Additionally, extensive literature on cancer invasion and Neu3 
sialidase exists showing that Neu3 sialidase is localized to membrane ruffles in GM1-rich 
rafts during metastasis (Miyagi et al., 2008; Miyata et al., 2011; Tringali et al., 2012; 
Yamaguchi et al., 2006). Metastatic transformation and growth cone advance share a 
requirement for membrane extension, decreased adhesiveness to substrate at the leading 
edge, and formation of fillipodia and lamellipodia.  In tumor cells, Neu3 sialidase has effects 
on adhesion, integrin turnover and activation, caspase activity, caveolins and several 
signalling pathways (Miyagi et al., 2008; Roche et al., 2007).  Disruption of 
microdomains/rafts might explain why mice lacking complex gangliosides have a marked 
decrease in expression levels of neurotrophic factors and their receptors (Kittaka et al., 
2008), and why GM1 ganglioside potentiates the activity of NGF receptor, TrkA, in addition 
to other neurotrophin receptors (Bahr et al., 1989; Cuello et al., 1994; Rabin et al., 2002; 
Rabin and Mocchetti, 1995).  Additionally, it is likely that Neu3 sialidase activation may lead 
to its association with integrins, further leading to activation of FAK and calcium influx (Wu 
et al., 2007), an event important for cytoskeletal reorganization and axonal guidance (Kato 




The experiments in this paper demonstrate that an increase in the ratio of growth-
promoting gangliosides (GM1) to growth-inhibiting gangliosides (GD1a and others including 
GT1b) mediated by Neu3 sialidase play an important part in changes that lead to axon 
regeneration after axotomy. Much of the detail about cytoskeletal changes that occur after 
axotomy is known (Erez et al., 2007; Erturk et al., 2007; Spira et al., 2003) and we are 
beginning to understand the process of local mRNA translation (Hanz et al., 2003; Vogelaar 
et al., 2009; Willis et al., 2005). Equally important are changes on the cell surface, and our 
results strongly suggest that understanding these events will enable interventions that 
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Figure 1: DRG axotomy causes a transient increase in the ratio of GM1/GD1a and 
GM1/GT1b gangliosides  
I - Schematic of experimental design.  II - Fluorescent images of adult DRG explants (D - I) or 
dissociated DRGs (K - P, R - W) with axons uncut (D, G, K, N, R, U), 15mins (E, H, L, O, S, V) or 
1h after axotomy (F, I, M, P, T, W).  DRGs are double-labelled for GD1a ganglioside (green) 
in D – I, K – P (or GT1b ganglioside in R – W) and Cholera toxin B subunit (CTB) – for GM1 
ganglioside (red) under normal conditions (D - F, K - M, R - T), after exposure to NeuAc2en 
(G - I), or after Neu3 siRNA transfection (N - P, U - W).  In this and subsequent images, 
axotomy/nerve crush is indicated by dashed yellow lines, where applicable.  GM1 and GD1a 
or GT1b ganglioside intensities were plotted (± SEM) in J (DRG explants, 40 – 50 
axons/chamber, 2 DRG/chamber, n≥4 chambers) or Q and X (dissociated DRGs, 2 
axons/chamber, n=5). III – Reduction of Neu3 expression with Neu3 siRNA. (V, W) 
Fluorescent images of adult DRG neurons after immunocytochemistry for Neu3 sialidase, 
without siRNA transfection (V), or after Neu3-siGLO transfection (W). Neurons transfected 
with Neu3-siGLO (red, W) have reduced intensity for Neu3 sialidase staining (green). (X) RT-
PCR of siRNA-transfected adult DRG neurons, run at 26, 29 and 32 cycles. Neu3 siRNA is 
specific in knocking down the expression of Neu3 by approximately 70%, and has no effect 
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on Neu4, a closely related sialidase. Controls are siGLO-transfected only neurons (non-
functional and non-targeting siRNA). *P<0.05, **P<0.01, ***P<0.001 calculated with one-
way or two-way ANOVA, where appropriate. Bars: 250µm (V-W), 25µm (A-F), 50µm (H-M, 
O-T).  
 
Figure 2: Reduction of Neu3 sialidase activity by the inhibitor, NeuAc2en, or by Neu3 
siRNA transfection reduced regeneration after axotomy but not axon growth rate.  
I - Phase contrast photomicrographs showing axons of DRG explants (A-D) or dissociated 
DRGs (F-K) immediately (A, C, F, I), 15 mins (dissociated DRGs only; G, J) or 1h after axotomy 
(B, D, H, K), under control conditions (A, B, F - H), and after exposure to NeuAc2en (C, D), or 
Neu3 siRNA transfection (I - K). Percent regeneration 1h after axotomy (± SEM) plotted in E 
(n=6 DRG explants) or following Neu3 siRNA transfection or L (2 axons/chamber, n=15 
chambers, dissociated DRGs). Arrows/arrowheads indicate axons that were cut, retracted at 
15min and regenerated at 1h.  The     (C,D) indicates an uncut axon which continued to 
grow in the presence of NeuAc2en.  The inset image (K) shows a merged phase contrast and 
fluorescent image of the DRG cell body from I - K demonstrating the presence of siGLO (red) 
confirming the siRNA uptake in the neuron. Controls (F - H) were performed with siGLO-
transfection only, or no treatment (A, B).  II (M-O) Phase contrast photo-montages of adult 
DRG axons 18h after exposure to PDMP (M), 1h after exposure to NeuAc2en (N), and 
control (O). Photo-montages from similar areas were taken before addition of drugs and 
analyzed for growth rate in these as well as in corresponding control axons. Axon lengths 
were measured in drug-treated cultures and compared with corresponding control cultures 
to calculate the growth rate of axons (in µm/h with ± SEM) which is plotted in P (each 
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column represents a mean of 30-40 axons from n=3 chambers/condition). ***P<0.001 
calculated using two-tailed Student’s t-test. Bars: 20m (A - D), 100m (F - K), 50µm (inset 
in K), 200µm (M - O). 
 
Figure 3: Neu3 sialidase is transiently activated in the sciatic nerve after crush injury. 
(A, A’) Confocal micrograph of sciatic nerve immunolabelled with S100β (green), CTB (red) 
and ßIII-tubulin (blue). Area within dotted line (A’) denotes representative regions parallel 
to axonal staining (blue) used to measure the intensities of GM1 and GD1a gangliosides. 
Schwann cell staining (green) performed to show its relative position to area of 
measurement. (B-D): Fluorescent confocal images (longitudinal) of sciatic nerve uncrushed 
(B, B’), 6h after crush (6hrs; C, C’) and 12h after crush (12hrs; D, D’), triple labelled for 
neurofilament-heavy chain (green), GD1a (blue) and GM1 gangliosides (CTB, red), with high 
magnification images from dotted squares shown on right. Arrows indicate representative 
regions adjacent and parallel to axonal staining (NF-H positive) used for measuring GM1 and 
GD1a gangliosides intensities. (E) The ratio of GM1/GD1a ganglioside intensities (± SEM) 
over time post-injury is plotted (n=6/time point). ***P<0.001, **P<0.01 calculated using 
one-way ANOVA.  Bars: 50µm (A-D), 25μm (A’-D’); orientation of figures: top = caudal, 
bottom = rostral. 
 
Figure 4: Exogenous sialidase rescues NeuAc2en-mediated inhibition of Neu3 sialidase 
activity and promotes axonal regeneration 
I – Schematic of experimental design for sialidase rescue experiments in adult DRG axons.  
II – (A-F) Fluorescent photomicrographs after exposure to Neu3 sialidase inhibitor 
(NeuAc2en) for 1h, which was removed and followed by no treatment (NeuAc2en + control; 
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A-C) or exposure to exogenous Clostridium sialidase (NeuAc2en + sialidase; D-F) with 
axotomy performed 30mins later showing adult DRG axons uncut (A, D), 15mins  (B, E) and 
1h after axotomy (C, F), double labelled for GD1a (green) and  GM1 gangliosides (CTB, red). 
The ratio of GM1/GD1a gangliosides (± SEM) was plotted in G, with the GM1 & GD1a 
ganglioside intensities ratio normalized to background (n≥4).  **P<0.01 and ***P<0.001 
calculated with 2-way ANOVA. (H-K) Phase contrast photomicrographs showing DRG axons 
immediately after axotomy (H, J) and 1h after exposure to NeuAc2en and removal 
(NeuAc2en + control; H, I), or after exposure to NeuAc2en followed by exogenous 
Clostridium sialidase (NeuAc2en + Sialidase; J, K). Arrows indicate selected axons at 
axotomy and after 1 h.  Percent regeneration (± SEM) 1h post-axotomy plotted in L (n=6).  
***P<0.001 calculated using student’s two-tailed t-test. Bars: 50µm (A-F) and 30µm (H-K). 
 
Figure 5: Neu3 sialidase remains inactivated after retina axonal injury; however 
exogenous sialidase can promote retinal axon regeneration.  
I – Schematic of timeline for retinal axon experiments.  
II (A-D) Fluorescent photomicrographs of adult retinal axons 15mins after axotomy. Axons 
are double labelled for GD1a (A, C) and GM1 gangliosides (CTB - B, D) under normal 
conditions (control 15mins; A-B) or after exposure to Clostridium sialidase (sialidase 
15mins; C-D). (E) Fluorescent photomicrograph showing Neu3 sialidase enzyme on an adult 
retinal axon. The ratio of GM1/GD1a ganglioside is plotted in F (30-40 axons/chamber, n≥6). 
(G-I) Fluorescent confocal photomicrographs (longitudinal) of optic nerve uncrushed (G, G’), 
6h (H, H’) and 12h after crush (I, I’), triple labelled for ßIII-tubulin (green), GD1a (blue) and 
GM1 gangliosides (CTB, red). High magnification images (‘) from the dotted squares in the 
corresponding pictures denote representative areas used for GD1a and GM1 quantification. 
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Arrows indicate regions parallel to axonal staining used for measuring intensities of GM1 
and GD1a gangliosides. The ratio of GM1/GD1a gangliosides (± SEM) parallel to axonal 
staining before and after optic nerve injury and normalized against background intensity 
levels is plotted in J (n=3). P values by one-way ANOVA.  (K-N) Phase contrast 
photomicrographs showing retinal axons at time of axotomy (0mins; K, M) and 1h post-
axotomy (1hr; L, N), retracting under normal conditions (control; K, L), or regenerating after 
exposure to Clostridium sialidase applied 30mins pre-axotomy (sialidase; M, N). Plots of 
mean distance of axon tip retraction from site of injury measured 1h post-injury in the 
presence or absence of exogenous sialidase (n≥6) (O) and percentage of axons that 
regenerated past retraction position in retinal axons 1h after injury (n≥6) (P) with ± SEM. P 
values (***P<0.001, *p<0.05) by student’s t-test (2-tailed). Bars: 100µm (A-D); 25µm (E, G’-
I’); 50µm (K-N, G-I).  
 
Figure 6: Axon regeneration is regulated by eCa2+, P38MAPK, ERK and mTOR signalling 
cascades.  (A-J) Phase contrast photomicrographs of adult DRG axons photographed 
immediately after axotomy (A-E) and 1h post-axotomy (F-J), under normal conditions 
(control; A, F) and after exposure to inhibitors of ERK (U0126; B, G), removal of Ca2+ (w/o 
calcium; C, H), inhibitors of P38MAPK (SB203580; D, I) and mTOR (rapamycin; E, J). 
Inhibition of all these pathways attenuated the ability of axons to regenerate.  Percent 
regeneration of axons (±SEM) is plotted in K (n≥5).  P values (***P<0.001) were calculated 
with one-way ANOVA. Bars: 50µm. 
 
Figure 7: Neu3 sialidase activity is affected by eCa2+, P38MAPK, and ERK in adult DRG 
axons after axotomy.   
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A-J: Fluorescent photomicrographs of adult DRG axons uncut (A-E) and 15mins after 
axotomy (F-J), double labelled for GD1a (green) and GM1 gangliosides (CTB, red) under 
normal conditions (control; A, F) and after exposure to inhibitors of ERK (U0126; B, G), 
removal of Ca2+ (w/o calcium; C, H), inhibitors of P38MAPK (SB203580; D, I) or mTOR 
(rapamycin; E, J). The ratio of GM1/GD1a ganglioside intensities (± SEM) normalized against 
background intensity levels is plotted in K (40 – 50 axons/chamber, 2 DRGs/chamber, n≥3 
chambers).  To avoid variability among uncut axons, axonal ratios of GM1/GD1a intensity 
levels were assigned the arbitrary value of 1 and GM1/GD1a levels at 15mins and 1h post-
axotomy were normalized against corresponding uncut axons’ ratio. (L-M) The ratio of 
pP38MAPK/P38MAPK (L; uncut, n=4; 15mins, n=6) and pERK/ERK (M; uncut, n=4; 15mins, 
n=4) uncut and 15mins after injury is plotted + SEM.  ***P<0.001, **P<0.01, *P<0.05 
calculated with two-way ANOVA (K) and student’s t-test (two-tailed) (L-M). Bars: 50µm (A-
J).  
 
Figure 8: P38MAPK activation is the intermediary step between eCa2+ influx and Neu3 
sialidase activation after axonal injury, while ERK activation is downstream of Neu3 
sialidase activation. 
I (A-E): Fluorescent photomicrographs of adult DRG axons uncut (A, C) and 15mins after 
axotomy (B, D), double labelled for P38MAPK (red) & phospho P38MAPK (green) under 
normal conditions (control; A-B) and after removal of eCa2+ (w/o Ca2+; C-D).  The ratio of 
phospho P38MAPK/P38MAPK intensities (± SEM) normalized against background intensity 
levels is plotted in E (30 – 40 axons/chamber, 2 DRGs/chamber, n=4-6 chambers).   
II – Activation of P38MAPK using anisomycin increases Neu3 sialidase activity even in the 
absence of eCa2+. (F-H): Fluorescent photomicrographs of uncut adult DRG axons, double 
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labelled for GD1a (green) and GM1 gangliosides (CTB, red) & under normal conditions 
(control; F), after removal of eCa2+ (w/o Ca2+; G) and after exposure to anisomycin (AIS) in 
the absence of eCa2+ (w/o Ca2+ + AIS; H). The ratio of GM1/GD1a ganglioside intensities (± 
SEM) normalized against background intensity levels is plotted in I (30 – 40 axons/chamber, 
2 DRGs/chamber, n=4 chambers).   
III – ERK activation is downstream of Neu3 sialidase activation. (J-L): Fluorescent 
photomicrographs of adult uncut DRG axons, labelled for pERK under control conditions (J) 
and after exposure to exogenous sialidase (K). The ratio of pERK/ERK intensities (± SEM) 
normalized against background intensity levels is plotted in L (30 – 40 axons/chamber, 
containing 2 DRGs, n=6 chambers). ***P<0.001, **P<0.01 calculated with student’s t-test 
(two-tailed). Bars: 50µm.  
 
Figure 9: P38MAPK and ERK are not activated within 15mins after axotomy in retinal 
axons, but forced activation of P38MAPK increases Neu3 sialidase activity in retinal axons. 
I (A-D): Fluorescent photomicrographs of adult retinal axons uncut (a, c) and 15mins after 
axotomy (B, D), double labelled for P38MAPK (A-B) or ERK (C-D) (red) & pP38MAPK (A-B) or 
pERK (C-D) (green).  Ratios of pP38MAPK/P38MAPK and pERK/ERK intensities (± SEM) 
normalized against background intensity levels are plotted in E and F (30 – 40 
axons/chamber, n=4 chambers).  
II (G-H): Fluorescent photomicrographs of adult uncut retinal axons, double-labelled for 
GD1a (green) and GM1 gangliosides (CTB, red) &. Anisomycin increased the GM1/GD1a 
ratio (compare H with G). (I) Ratios of GM1/GD1a ganglioside intensities (± SEM) normalized 
against background intensity levels are plotted in I (30 – 40 axons/chamber, n≥7). 




Figure 10: Diagram of proposed signalling cascade regulating Neu3 sialidase activity 
Membrane rupture post-axotomy leads to increased influx of eCa2+ into injured axons. 
While in adult DRGs this results in either direct activation of Neu3 sialidase or an increased 
phosphorylation of P38MAPK resulting in increased Neu3 sialidase activation, this process is 
absent in adult retinal axons. Furthermore, ERK is activated downstream of Neu3 sialidase 
which in turn further activates Neu3 sialidase through a positive feedback loop – a step 
attenuated in retinal axons, resulting in a 2-step block for successful Neu3 sialidase activity 
mediated regeneration. 
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